Bayer Stock - Week in review and pharma sector comparison
19.06.2026 - 17:38:54 | ad-hoc-news.de
Edited by ad hoc news Sector & Peer-Group Desk. Verified prior to publication on 06/19/2026, 17:37 CET. Details in the imprint.
Bayer (DE000BAY0017) spent this week trading without a fresh company-specific catalyst, while legal headlines and sector moves continued to shape sentiment. On Friday, the stock lagged a broadly cautious European pharmaceuticals complex, according to exchange data.
All news and background on Bayer stock
Charts, filings and previous headlines on Bayer give additional context for this week’s trading and the stock’s position in the European pharma sector.
How Bayer shares traded this week
On Xetra, Bayer shares recently changed hands at around EUR 37, which implies a weekly performance roughly in line with the broader DAX over the last five sessions, according to intraday exchange data.
Trading volumes stayed close to the 3-month daily average, signaling neither pronounced capitulation nor renewed risk appetite from investors during the week.
Where the sector stands on Friday
Peers such as Novartis and Sanofi also posted soft moves over the week, as European pharma stocks digested macro worries and ongoing drug-pricing debates, according to regional market overviews.
The STOXX Europe 600 Health Care index showed a similarly muted picture, with defensive rotation into pharmaceuticals partly offset by concerns over litigation and policy risk in several large names.
How the company makes its money
Bayer generates revenue from three main businesses: pharmaceuticals, consumer health products like Aspirin, and crop science solutions ranging from seeds to crop protection chemicals, according to company disclosures.
Where the stock trades today
The shares of Bayer (DE000BAY0017) trade on Xetra at EUR 37.46 as of 06/19/2026, 17:30 CET.
Key facts on Bayer stock
- Company: Bayer Aktiengesellschaft
- ISIN: DE000BAY0017
- WKN: BAY001
- Ticker: BAYN
- Venue: Xetra
- Price (as of 06/19/2026, 17:30 CET): 37.46 EUR
- Market cap: 36,000,000,000 EUR (as of 06/19/2026)
- Sector / Industry: Health Care / Pharmaceuticals & Life Sciences
- Index membership: DAX, Euro Stoxx 50, Stoxx Europe 600
- Next earnings date: 08/07/2026
This article was AI-assisted and editorially reviewed. Price and company data without warranty; prices and dates may change at short notice. No investment advice, no buy or sell recommendation. Trading securities involves risk up to total loss of capital.
